Nocturnal, sleeping IOP keeps ophthalmologists up at night

Article

There is much to be learned about nocturnal-and, more importantly, sleeping-IOP if ophthalmologists are going to optimize glaucoma therapies, said Yaniv Barkana, MD, Department of Ophthalmology, Assaf Harofeh Medical Center, Israel.

There is much to be learned about nocturnal-and, more importantly, sleeping-IOP if ophthalmologists are going to optimize glaucoma therapies, said Yaniv Barkana, MD, Department of Ophthalmology, Assaf Harofeh Medical Center, Israel.

"What happens to IOP during the one-third of our lives that we're asleep? We know from several recent studies, and some not-so-recent, that supine, nighttime IOP is higher than daytime sitting IOP, in some cases on the order of 4 mm," Dr. Barkana said. "This may mean that glaucoma progression takes place while we are sleeping."

Unfortunately, Dr. Barkana said, there is not any single best way to measure IOP during sleep.

"Keep in mind that measuring nocturnal IOP is not the same as measuring sleeping IOP," he said. "We can measure IOP after waking patients, but even if we wake them gently, the change from sleeping to waking changes the equation."

Having an analysis of sleeping IOP could have implications for making a diagnosis of normal-tension glaucoma and increase the understanding of the mechanism of normal-tension glaucoma, according to Dr. Barkana. It may also alter treatment regimens.

"It may be that we choose to design and pursue therapies designed to blunt the sleeping IOP rise," he said.

Tools may become available for clinicians in the near future to help answer the question of what IOP is doing as we sleep, Dr. Barakana said. Implantable or contact lens-mounted monitors may allow for continuous IOP monitoring that may lead to new ways of thinking about glaucoma management.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.